Huiping Zhu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Huiping Zhu has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Richard H. Finnell
Center for Precision Environmental Health, Departments of Molecular and Human Genetics, Molecular and Cellular Biology and Medicine, Baylor College of Medicine, Houston, USA
5 shared publications Gary M. Shaw
Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA
4 shared publicationsMark A. Canfield
Texas Department of State Health Services, Austin, TX, USA
3 shared publications- Philip J. Lupo
Department of Pediatrics Emory University School of Medicine Atlanta Georgia USA
3 shared publications Andrew F. Olshan
Department of Epidemiology, University of North Carolina, Chapel Hill, NC, USA
2 shared publicationsClaudia Chapa
2 shared publications
Latest Publications
- 1 January 2014
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 111 (1) , 46-51
Maternal–fetal metabolic gene–gene interactions and risk of neural tube defects
- 1 January 2014
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 111 (1) , 46-51
Maternal–fetal metabolic gene–gene interactions and risk of neural tube defects
- Open Access
- 6 November 2012
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 176 (12) , 1101-1109
Diabetes and Obesity-Related Genes and the Risk of Neural Tube Defects in the National Birth Defects Prevention Study
Few studies have evaluated genetic susceptibility related to diabetes and obesity as a risk factor for neural tube defects (NTDs). The authors investigated 23 single nucleotide polymorphisms among 9 genes (ADRB3, ENPP1, FTO, LEP, PPARG, PPARGC1A, SLC2A2, TCF7L2, and UCP2) associated with type 2 diabetes or obesity. Samples were obtained from 737 NTD case-parent triads included in the National Birth Defects Prevention Study during 1999–2007. Log-linear models were used to evaluate maternal and offspring genetic effects. After application of the false discovery rate, there were 5 significant maternal genetic effects. The less common alleles at the 4 FTO single nucleotide polymorphisms showed a reduction of NTD risk (for rs1421085, relative risk (RR) = 0.73 (95% confidence interval (CI): 0.62, 0.87); for rs8050136, RR = 0.79 (95% CI: 0.67, 0.93); for rs9939609, RR = 0.79 (95% CI: 0.67, 0.94); and for rs17187449, RR = 0.80 (95% CI: 0.68, 0.95)). Additionally, maternal LEP rs2071045 (RR = 1.31, 95% CI: 1.08, 1.60) and offspring UCP2 rs660339 (RR = 1.32, 95% CI: 1.06, 1.64) were associated with NTD risk. Furthermore, the maternal genotype for TCF7L2 rs3814573 suggested an increased NTD risk among obese women. These findings indicate that maternal genetic variants associated with glucose homeostasis may modify the risk of having an NTD-affected pregnancy.
- 6 November 2012
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 176 (12) , 1101-1109
Open AccessDiabetes and Obesity-Related Genes and the Risk of Neural Tube Defects in the National Birth Defects Prevention Study
Few studies have evaluated genetic susceptibility related to diabetes and obesity as a risk factor for neural tube defects (NTDs). The authors investigated 23 single nucleotide polymorphisms among 9 genes (ADRB3, ENPP1, FTO, LEP, PPARG, PPARGC1A, SLC2A2, TCF7L2, and UCP2) associated with type 2 diabetes or obesity. Samples were obtained from 737 NTD case-parent triads included in the National Birth Defects Prevention Study during 1999–2007. Log-linear models were used to evaluate maternal and offspring genetic effects. After application of the false discovery rate, there were 5 significant maternal genetic effects. The less common alleles at the 4 FTO single nucleotide polymorphisms showed a reduction of NTD risk (for rs1421085, relative risk (RR) = 0.73 (95% confidence interval (CI): 0.62, 0.87); for rs8050136, RR = 0.79 (95% CI: 0.67, 0.93); for rs9939609, RR = 0.79 (95% CI: 0.67, 0.94); and for rs17187449, RR = 0.80 (95% CI: 0.68, 0.95)). Additionally, maternal LEP rs2071045 (RR = 1.31, 95% CI: 1.08, 1.60) and offspring UCP2 rs660339 (RR = 1.32, 95% CI: 1.06, 1.64) were associated with NTD risk. Furthermore, the maternal genotype for TCF7L2 rs3814573 suggested an increased NTD risk among obese women. These findings indicate that maternal genetic variants associated with glucose homeostasis may modify the risk of having an NTD-affected pregnancy.
- 1 November 2012
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 107 (3) , 592-595
A GCH1 haplotype and risk of neural tube defects in the National Birth Defects Prevention Study
- 1 November 2012
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 107 (3) , 592-595
A GCH1 haplotype and risk of neural tube defects in the National Birth Defects Prevention Study
- 11 April 2012
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 158A (5) , 1124-1134
Gene variants in the folate‐mediated one‐carbon metabolism (FOCM) pathway as risk factors for conotruncal heart defects
We evaluated 35 variants among four folate‐mediated one‐carbon metabolism pathway genes, MTHFD1, SHMT1, MTHFR, and DHFR as risk factors for conotruncal heart defects. Cases with a diagnosis of single gene disorders or chromosomal aneusomies were excluded. Controls were randomly selected from area hospitals in proportion to their contribution to the total population of live‐born infants. Odds ratios (OR) and the 95% confidence intervals (CI) were computed for each genotype (homozygous variant or heterozygote, vs. homozygous wildtype) and for increase of each less common allele (log‐additive model). Interactions between each variant and three folate intake variables (maternal multivitamin use, maternal dietary folate intake, and combined maternal folate intake) were also evaluated under the log‐additive model. In general, we did not identify notable associations. The A allele of MTHFD1 rs11627387 was associated with a 1.7‐fold increase in conotruncal defects risk in both Hispanic mothers (OR = 1.7, 95% CI = 1.1–2.5) and Hispanic infants (OR = 1.7, 95% CI = 1.2–2.3). The T allele of MTHFR rs1801133 was associated with a 2.8‐fold increase of risk among Hispanic women whose dietary folate intake was ≤25th centile. The C allele of MTHFR rs1801131 was associated with a two‐fold increase of risk (OR = 2.0, 95% CI = 1.0–3.9) only among those whose dietary folate intake was >25th centile. Our study suggested that MTHFD1 rs11627387 may be associated with risk of conotruncal defects through both maternal and offspring genotype effect among the Hispanics. Maternal functional variants in MTHFR gene may interact with dietary folate intake and modify the conotruncal defects risk in the offspring.
- 11 April 2012
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 158A (5) , 1124-1134
Gene variants in the folate‐mediated one‐carbon metabolism (FOCM) pathway as risk factors for conotruncal heart defects
We evaluated 35 variants among four folate‐mediated one‐carbon metabolism pathway genes, MTHFD1, SHMT1, MTHFR, and DHFR as risk factors for conotruncal heart defects. Cases with a diagnosis of single gene disorders or chromosomal aneusomies were excluded. Controls were randomly selected from area hospitals in proportion to their contribution to the total population of live‐born infants. Odds ratios (OR) and the 95% confidence intervals (CI) were computed for each genotype (homozygous variant or heterozygote, vs. homozygous wildtype) and for increase of each less common allele (log‐additive model). Interactions between each variant and three folate intake variables (maternal multivitamin use, maternal dietary folate intake, and combined maternal folate intake) were also evaluated under the log‐additive model. In general, we did not identify notable associations. The A allele of MTHFD1 rs11627387 was associated with a 1.7‐fold increase in conotruncal defects risk in both Hispanic mothers (OR = 1.7, 95% CI = 1.1–2.5) and Hispanic infants (OR = 1.7, 95% CI = 1.2–2.3). The T allele of MTHFR rs1801133 was associated with a 2.8‐fold increase of risk among Hispanic women whose dietary folate intake was ≤25th centile. The C allele of MTHFR rs1801131 was associated with a two‐fold increase of risk (OR = 2.0, 95% CI = 1.0–3.9) only among those whose dietary folate intake was >25th centile. Our study suggested that MTHFD1 rs11627387 may be associated with risk of conotruncal defects through both maternal and offspring genotype effect among the Hispanics. Maternal functional variants in MTHFR gene may interact with dietary folate intake and modify the conotruncal defects risk in the offspring.
- Open Access
- 8 October 2010
- Published by Springer Nature in BMC Medical Genetics
- Vol. 11 (1) , 141
Genes encoding critical transcriptional activators for murine neural tube development and human spina bifida: a case-control study
Background: Spina bifida is a malformation of the neural tube and is the most common of neural tube defects (NTDs). The etiology of spina bifida is largely unknown, although it is thought to be multi-factorial, involving multiple interacting genes and environmental factors. Mutations in transcriptional co-activator genes-Cited2,p300,Cbp,Tfap2α,Carm1andCart1result in NTDs in murine models, thus prompt us to investigate whether homologues of these genes are associated with NTDs in humans.Methods: Data and biological samples from 297 spina bifida cases and 300 controls were derived from a population-based case-control study conducted in California. 37 SNPs withinCITED2,EP300,CREBBP,TFAP2A,CARM1andALX1were genotyped using an ABI SNPlex assay. Odds ratios and 95% confidence intervals were calculated for alleles, genotypes and haplotypes to evaluate the risk for spina bifida.Results: Several SNPs showed increased or decreased risk, includingCITED2rs1131431 (OR = 5.32, 1.04~27.30),EP300rs4820428 (OR = 1.30, 1.01~1.67),EP300rs4820429 (OR = 0.50, 0.26~0.50, in whites, OR = 0.7, 0.49~0.99 in all subjects),EP300rs17002284 (OR = 0.43, 0.22~0.84),TFAP2Ars3798691 (OR = 1.78, 1.13~2.87 in Hispanics),CREBBPrs129986 (OR = 0.27, 0.11~0.69),CARM1rs17616105 (OR = 0.41, 0.22~0.72 in whites). In addition, one haplotype block inEP300and one inTFAP2Aappeared to be associated with increased risk.Conclusions: Modest associations were observed inCITED2,EP300,CREBBP,TFAP2AandCARM1but notALX1. However, these modest associations were not statistically significant after correction for multiple comparisons. Searching for potential functional variants and rare causal mutations is warranted in these genes.
- 8 October 2010
- Published by Springer Nature in BMC Medical Genetics
- Vol. 11 (1) , 141
Open AccessGenes encoding critical transcriptional activators for murine neural tube development and human spina bifida: a case-control study
Background: Spina bifida is a malformation of the neural tube and is the most common of neural tube defects (NTDs). The etiology of spina bifida is largely unknown, although it is thought to be multi-factorial, involving multiple interacting genes and environmental factors. Mutations in transcriptional co-activator genes-Cited2,p300,Cbp,Tfap2α,Carm1andCart1result in NTDs in murine models, thus prompt us to investigate whether homologues of these genes are associated with NTDs in humans.Methods: Data and biological samples from 297 spina bifida cases and 300 controls were derived from a population-based case-control study conducted in California. 37 SNPs withinCITED2,EP300,CREBBP,TFAP2A,CARM1andALX1were genotyped using an ABI SNPlex assay. Odds ratios and 95% confidence intervals were calculated for alleles, genotypes and haplotypes to evaluate the risk for spina bifida.Results: Several SNPs showed increased or decreased risk, includingCITED2rs1131431 (OR = 5.32, 1.04~27.30),EP300rs4820428 (OR = 1.30, 1.01~1.67),EP300rs4820429 (OR = 0.50, 0.26~0.50, in whites, OR = 0.7, 0.49~0.99 in all subjects),EP300rs17002284 (OR = 0.43, 0.22~0.84),TFAP2Ars3798691 (OR = 1.78, 1.13~2.87 in Hispanics),CREBBPrs129986 (OR = 0.27, 0.11~0.69),CARM1rs17616105 (OR = 0.41, 0.22~0.72 in whites). In addition, one haplotype block inEP300and one inTFAP2Aappeared to be associated with increased risk.Conclusions: Modest associations were observed inCITED2,EP300,CREBBP,TFAP2AandCARM1but notALX1. However, these modest associations were not statistically significant after correction for multiple comparisons. Searching for potential functional variants and rare causal mutations is warranted in these genes.